News and Trends 13 Jul 2015
After being rejected twice, Horizon pushes Depomed to accept its €2.7Bn offer
Horizon Pharma is getting anxious and has offered the substantial amount of €2.7Bn to buy its American competitor Depomed. The Irish…
Neurological disorders
- Latest Posts
News and Trends 10 Jul 2015
First-in-human successful Phase I for an Alzheimer’s vaccine
AXON Neuroscience has completed a pioneer Phase I that offers new hope for millions of patients with Alzheimer’s disease. This…
News and Trends 2 Jul 2015
Roche and Evotec knocked down by their Alzheimer candidate
The progressive aging of the population in developed countries is turning Alzheimer into one of the biggest medical challenges of…
News and Trends 4 Mar 2015
Alkermes presents its new treatment of Alzheimer’s agitation
Alkermes reveals a new drug candidate, ALKS 7119, for treatment of Alzheimer’s agitation, depression and other central nervous system (CNS)…
ADVERTISEMENT
News and Trends 18 Feb 2015
#BioFigures: 3,000 whole genomes sequenced to fight Parkinson!
WHO? 23andMe, founded in 2006, is the leading personal genetics company dedicated to helping people access, understand and benefit from…
News and Trends 11 Feb 2015
AB Science: One step further towards a cure to Alzheimer’s disease
AB Science SA, a pharmaceutical company specialized in research, development and marketing of protein kinase inhibitors (PKIs), today announced the…
News and Trends 21 Aug 2014
Stemedica International succeed in a pre-clinical trial to treat Alzheimer’s disease with stem cells
Stemedica International, a Stemedica Cell Technologies Inc. subsidiary developing stem cell therapies for Alzheimer’s disease and dementia, revealed the first…
